618 Phase 1 clinical trial evaluating the safety, biologic and anti-tumor activity of the novel STING agonist IMSA101 administered both as monotherapy and in combination with PD-(L)1 checkpoint inhibitors

618 Phase 1 clinical trial evaluating the safety, biologic and anti-tumor activity of the novel STING agonist IMSA101 administered both as monotherapy and in combination with PD-(L)1 checkpoint inhibitors

書誌詳細
主要な著者:	Syed Kazmi, Lijun Sun, Angela Alistar, Ezra Cohen, Timothy Yap, Devalingam Mahalingam, Justin C Moser, Edward Garmey, Teresa Mooneyham
フォーマット:	論文
言語:	English
出版事項:	BMJ Publishing Group 2023-11-01
シリーズ:	Journal for ImmunoTherapy of Cancer

類似資料

The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretion
著者:: Ugur Uslu, 等
出版事項: (2024-05-01)

Overview of the IMSA project, a patient-oriented information system
著者:: Olivier Curé
出版事項: (2006-01-01)

ویژگی‌های روان‌سنجی پرسشنامه انگیزه‌های اقدام به خودکشی (IMSA)
著者:: محمد جواد بگیان, 等
出版事項: (2019-02-01)

IMSA: integrated metagenomic sequence analysis for identification of exogenous reads in a host genomic background.
著者:: Michelle T Dimon, 等
出版事項: (2013-01-01)

Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Production by Enhancing the Activation of STING-TBK1 Signaling
著者:: Petcharat K, 等
出版事項: (2023-11-01)

Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
著者:: Jiajia Chang, 等
出版事項: (2023-03-01)

Oncolytic adenovirus H101 ameliorate the efficacy of anti‐PD‐1 monotherapy in colorectal cancer
著者:: Lili Huang, 等
出版事項: (2022-12-01)

Agonists and Inhibitors of the cGAS-STING Pathway
著者:: Xiaoxuan Yu, 等
出版事項: (2024-06-01)

Trial watch: STING agonists in cancer therapy
著者:: Julie Le Naour, 等
出版事項: (2020-01-01)

Sensors and actuators 1985 : SP-618
著者:: Society of Automotive Engineers (United States)
出版事項: (1985)

Effects of STING stimulation on macrophages: STING agonists polarize into “classically” or “alternatively” activated macrophages?
著者:: Takayuki Ohkuri, 等
出版事項: (2018-02-01)

ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance
著者:: Su Chul Jang, 等
出版事項: (2021-04-01)

Translation and Cross-Cultural Adaptation of the Japanese Version of the INTERMED Self-Assessment Questionnaire (IMSA) for Patient-Case Complexity Assessment
著者:: Yokokawa D, 等
出版事項: (2022-07-01)

Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
著者:: Ming Yi, 等
出版事項: (2022-10-01)

STING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments
著者:: Danilo Guerini
出版事項: (2022-03-01)

AGW 618 - MARKETING MANAGEMENT SEPT.1999.
著者:: PPP, Pusat Pengajian Pengurusan
出版事項: (1999)

AGW 618 - MARKETING MANAGEMENT SEPT 1999.
著者:: PPP, Pusat Pengajian Pengurusan
出版事項: (1999)

Dopamine agonist monotherapy utilization in patients with Parkinson’s disease
著者:: Monica Frazer, 等
出版事項: (2023-01-01)

STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance
著者:: Tianye Li, 等
出版事項: (2024-03-01)

Establishment and application of isothermal multiple-self-matching-initiated amplification (IMSA) in detecting Type II heat-labile enterotoxin of Escherichia coli.
著者:: Wenxin Liu, 等
出版事項: (2019-01-01)

Polymeric STING pro-agonists for tumor-specific sonodynamic immunotherapy
著者:: Yu, Jie, 等
出版事項: (2023)

A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists
著者:: Yu‐an Li, 等
出版事項: (2025-01-01)

Profile of STING agonist and inhibitor research: a bibliometric analysis
著者:: Xuemei Wang, 等
出版事項: (2025-02-01)

Inhibition Effect of STING Agonist SR717 on PRRSV Replication
著者:: Xuanying Si, 等
出版事項: (2024-08-01)

Antitumor Effect of Platinum-Modified STING Agonist MSA‑2
著者:: Mo Wang, 等
出版事項: (2024-01-01)

Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
著者:: Xi Chen, 等
出版事項: (2024-01-01)

Anticancer Effect of STING Agonist-Encapsulated Liposomes on Breast Cancer
著者:: Jibing Zhang, 等
出版事項: (2023-04-01)

Epigenetic state determines the in vivo efficacy of STING agonist therapy
著者:: Rana Falahat, 等
出版事項: (2023-03-01)

AGW 618 - MARKETING MANAGEMENT SEPT 1999.pdf
著者:: PPP, Pusat Pengajian Pengurusan
出版事項: (1999)

AGW 618 - Marketing Management - August - September 1998
著者:: PPP, Pusat Pengajian Pengurusan
出版事項: (1998)

Guanyin (Avalokiteshvara), China, Tang-dynastie (618-907)
著者:: K. Ruitenbeek
出版事項: (1989-09-01)

Specific DNAzymes cleave the 300–618 nt of 5′UTR to inhibit DHAV-1 translation and replication
著者:: Yanglin Li, 等
出版事項: (2022-12-01)

miR-618: possible control over TIMP-1 and its expression in localized prostate cancer
著者:: Renato F. Ivanovic, 等
出版事項: (2018-10-01)

CircRNA circ-ATAD1 suppresses miR-618 maturation to participate in colorectal cancer
著者:: Li Cao, 等
出版事項: (2022-05-01)

CSF3R T618I Collaborates With RUNX1-RUNX1T1 to Expand Hematopoietic Progenitors and Sensitizes to GLI Inhibition
著者:: Anja S. Swoboda, 等
出版事項: (2023-10-01)

The Potential Antidepressant Action of Duloxetine Co-Administered with the TAAR1 Receptor Agonist SEP-363856 in Mice
著者:: Xia Ren, 等
出版事項: (2022-04-01)

Absence of PSA Flare With Apalutamide Administered 1 Hour in Advance With GnRH Agonists: Case Report
著者:: Zhiquan Hu, 等
出版事項: (2022-05-01)

Human biodistribution and dosimetry of ¹¹C-CUMI-101, an agonist radioligand for serotonin-1a receptors in brain.
著者:: Christina S Hines, 等
出版事項: (2011-01-01)

5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation
著者:: Burcu Temizoz, 等
出版事項: (2024-03-01)

Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
著者:: Crespo, Monica P., 等
出版事項: (2015)